Zim Laboratories logo

Zim Laboratories

ZIMLAB NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹711 Cr
Volatility
Moderate
P/E Ratio
183.18
EBITDA
₹41.40 Cr
Return on Equity
1.97%
Debt to Equity
0.43
Book Value
₹54.77
52W High
₹144.49
52W Low
₹59.31

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company's working capital requirements have reduced from 52.8 days to 41.0 days

Weaknesses

7
  • Stock is trading at 2.52 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 4.03% over past five years.
  • Promoter holding is low: 30.4%
  • Company has a low return on equity of 4.54% over last 3 years.
  • Earnings include an other income of Rs.10.9 Cr.

Growth Rate

Revenue Growth
0.26% higher than 3Y
Net Income Growth
-52.46% lower than 3Y
Cash Flow Change
20.36% lower than 3Y
ROE
-59.13% lower than 3Y
ROCE
-36.11% higher than 3Y
EBITDA Margin (Avg.)
-16.63% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
67.44
85.83
96.29
118
81.82
92.14
96.33
109
71.76
88.71
109
105
94.18
Expenses
62.62
76.5
84.75
102
73.78
82.61
84.77
94.13
67.51
82.95
95.85
98.08
91.73
Operating Profit
4.82
9.33
11.54
15.65
8.04
9.53
11.56
14.6
4.25
5.76
12.81
7.19
2.45
OPM %
7.15%
10.87%
11.98%
13.28%
9.83%
10.34%
12%
13.43%
5.92%
6.49%
11.79%
6.83%
2.6%
Other Income
1.12
1.42
1.11
1.53
1
1.32
1.75
1.71
1.48
2.04
1.7
6.16
0.99
Interest
1.73
1.22
1.7
2.28
2.86
2.89
2.73
2.91
3.3
3.16
3.43
3.31
3.64
Depreciation
4.03
4.09
3.94
3.91
4.94
5
4.88
5.29
4.86
4.98
5.03
5.1
5.37
PBT
0.18
5.44
7.01
10.99
1.24
2.96
5.7
8.11
-2.43
-0.34
6.05
4.94
-5.57
Tax %
-22.22%
23.71%
31.81%
26.48%
27.42%
19.59%
30%
39.7%
-22.63%
23.53%
27.27%
24.29%
-28.01%
Net Profit
0.23
4.15
4.78
8.09
0.9
2.38
4
4.88
-1.87
-0.42
4.4
3.74
-4.02
EPS in Rs
0.05
0.85
0.98
1.66
0.18
0.49
0.82
1
-0.38
-0.09
0.9
0.7
-0.75
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
266
269
235
273
335
278
307
333
399
367
379
374
397
Expenses
278
239
203
238
293
255
268
292
347
326
335
344
369
Operating Profit
-12
30
32
35
42
23
40
41
52
41
44
30
28
OPM %
-4.4%
11%
13%
13%
13%
8%
13%
12%
13%
11%
12%
8%
7%
Other Income
2
-2
5
9
2
5
-3
4
6
5
6
11
11
Interest
10
14
10
9
11
13
11
8
6
7
11
13
14
Depreciation
7
9
9
10
11
14
16
16
17
16
20
20
20
PBT
-27
5
18
25
22
0
10
21
35
24
18
8
5
Tax %
-19%
5%
-6%
23%
30%
-4600%
28%
31%
31%
27%
32%
29%
—
Net Profit
-22
5
19
19
15
3
7
15
24
17
12
6
4
EPS in Rs
—
—
—
—
3.17
0.68
1.5
2.99
5.01
3.54
2.5
1.09
0.76
Div. Payout %
0%
16%
4%
4%
5%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
8
8
8
8
16
16
16
16
49
49
49
54
Reserves
86
91
110
129
135
138
145
159
152
190
204
243
Borrowings
93
96
81
81
77
90
82
53
62
112
118
127
Other Liabilities
78
61
60
81
100
82
82
112
79
96
102
116
Total Liabilities
265
256
259
298
328
325
325
342
342
447
472
539
Fixed Assets
87
92
89
94
106
116
107
106
109
161
164
162
CWIP
6
3
4
8
13
10
11
12
27
42
70
96
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
172
161
166
196
209
200
208
224
206
244
237
282
Total Assets
265
256
259
298
328
325
325
342
342
447
472
539
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
22
32
37
35
22
32
49
38
16
41
50
Investing
—
-12
-7
-26
-21
-19
-6
-14
-35
-73
-40
-55
Financing
—
-10
-25
-10
-15
-2
-26
-33
1
60
-9
28
Net Cash Flow
—
0
0
1
-1
1
0
2
3
3
-8
23
Free Cash Flow
—
9
24
8
15
3
25
34
1
-57
1
11
CFO/OP
—
77
109
117
85
119
83
121
86
46
92
177
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
111
120
137
119
101
89
86
98
87
100
103
106
Inventory Days
93
87
108
134
126
144
125
171
99
173
188
207
Days Payable
129
109
137
172
165
168
149
185
107
133
151
161
Cash Conversion Cycle
75
99
108
81
63
65
62
85
79
140
140
152
Working Capital Days
38
34
54
37
39
46
49
67
67
57
60
41
ROCE %
—
13%
14%
14%
15%
5%
11%
12%
17%
10%
8%
5%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Zim Laboratories insights

53 extracted metrics + investor summaries across FY14–FY26.

Log in — free

Shareholding Pattern

FIIs0.03%Others36.46%DIIs1.33%Promot.30.36%Public31.82%As ofJun 2026

Documents

Frequently Asked Questions about Zim Laboratories

What does Zim Laboratories Ltd do?
Incorporated in 1989, Zim Laboratories Ltd manufactures formulation drugs and pre formulation ingredients in India and markets and sells these within and out side India[1]
Where is Zim Laboratories Ltd (ZIMLAB) listed?
Zim Laboratories Ltd trades as ZIMLAB on the NSE and under code 541400 on the BSE.
Which sector does Zim Laboratories Ltd belong to?
Zim Laboratories Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.
What is the market capitalisation of Zim Laboratories Ltd?
Zim Laboratories Ltd has a market capitalisation of ₹711.24 Cr, which places it in the Small Cap band.
What is the PE ratio of Zim Laboratories Ltd?
Zim Laboratories Ltd trades at a PE ratio of 183.18, against a book value of ₹54.77 per share.
What is the 52-week high and low of Zim Laboratories Ltd?
Over the last 52 weeks Zim Laboratories Ltd has traded between ₹59.31 and ₹144.49.
What is the Return on Equity (ROE) of Zim Laboratories Ltd?
Zim Laboratories Ltd reported a return on equity of 1.97%. Its debt-to-equity ratio is 0.43.

Company Information

Incorporated in 1989, Zim Laboratories Ltd manufactures formulation drugs and pre formulation ingredients in India and markets and sells these within and out side India[1]

Website zimlab.in
CEO Dr. Anwar Siraj Daud M.Pharm
Employees 577
Listed 2018-06-08
Face Value ₹ 10
Issued Size 4,87,35,814

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ZIMLAB.md for Zim Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List